Healthcare News and Research

Latest Healthcare News and Research

The obese, people with AIDS encounter coverage gaps

Many plans sold through the health law's marketplaces don't cover weight loss surgery, and none in Louisiana are accepting payments from a federal program intended to help people with HIV/AIDS. The New York Times explores who benefits from the latest employer mandate extension, and Kaiser Health News answers a question about the health law's impact on a person covered by COBRA.

17 Feb 2014

Researchers use new technique that can partially move tumors from inoperable locations in brain

One factor that makes glioblastoma cancers so difficult to treat is that malignant cells from the tumors spread throughout the brain by following nerve fibers and blood vessels to invade new locations.

17 Feb 2014

Highlights: N.D. hospital and abortion docs; Calif. sugary beverage bill; aging home care workers in Texas

A Democratic candidate who has explicitly defended Obamacare holds a slight lead in a special congressional election in Florida that both parties are eyeing as a test of the political impact of the healthcare law. A poll released Thursday by the Tampa Bay Times shows Democrat Alex Sink leading her Republican opponent, David Jolly, 42% to 35% among people considered likely to vote in the March 11 special election.

17 Feb 2014

Study explains clinical, public health challenges for use of statins in treatment of heart attacks

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean, and Ira J. Gelb, M.D., emeritus professor of cardiology and senior advisor to the dean for pre-baccalaureate programs at FAU's Charles E. Schmidt College of Medicine, have published an invited editorial in the current issue of Cardiology about the clinical and public health challenges to increase utilization of statins in the treatment and prevention of heart attacks and strokes.

17 Feb 2014

Viewpoints: Parsing Obamacare numbers; experts on long-term care insurance; French cancer care

The monthly announcement of Obamacare's enrollment figures has become an exercise in confirmation bias, starting with the administration itself. Health and Human Services Secretary Kathleen Sebelius noted the "encouraging trends" in yesterday's release, while House Speaker John Boehner opted to highlight its "embarrassing failures." ... The only debate worth having is how to improve enrollment. ... enrollment numbers for Obamacare aren't some referendum on the president's popularity or lack thereof. They're the best way to tell whether the law is working as planned -- and how to adjust if it isn't (2/13).

17 Feb 2014

Some having new luck with healthcare.gov, but others remain stuck

Quiet fixes to healthcare.gov are helping some shoppers on the troubled website, but some still remain without insurance coverage. In the meantime, insurers are skeptical the latest marketplace enrollment numbers are cause for health law optimism.

17 Feb 2014

Leicester research reveals how noise damages hearing system

A research team investigating tinnitus, from the University of Leicester, has revealed new insights into the link between the exposure to loud sounds and hearing loss.

17 Feb 2014

Some states beating others to health law enrollment punch

News outlets take closer looks at the Obama administration's health law enrollment figures and find that some states are far outpacing others. Marketplace problems that persist in some states are also examined.

16 Feb 2014

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.

16 Feb 2014

Finding the meaning behind new Obamacare enrollment numbers

As the president renews his call for people -- especially African Americans and Latinos -- to enroll for insurance coverage, news outlets detail what is actually known about who has already signed up.

16 Feb 2014

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

Research roundup: Examining readmissions; easing doctor burnout

Despite massive early IT problems, exchange enrollment is accelerating rapidly. While enrollment may not reach 7 million by the end of March, we expect at least 5 million to have enrolled by the close of the initial open-enrollment period. If enrollment falls far short, HHS could extend open enrollment for a fixed period to reach its 7 million target. ... We project that 5 million new beneficiaries will be covered by Medicaid and the Children's Health Insurance Program by the end of 2014. Medicaid managed-care enrollment of non-dual beneficiaries will increase by 20 percent from 2013 to 2014 and by 38 percent from 2013 to 2016. We expect that 75 percent of non-dual Medicaid beneficiaries will be covered by Managed Care Organizations starting in 2015, up from 63 percent in 2012 (Feb. 2014).

14 Feb 2014

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch® DispoLED™ Single-Use Fiber Optic Laryngoscope Handle — a cost-neutral way to combat cross-contamination infection risk during intubation.

14 Feb 2014

First Edition: February 14, 2014

Today's early morning highlights from the major news organizations, including reports on the least expensive health insurance markets and efforts to set up skimpier plans under the health law.

14 Feb 2014

Improper handling of intravenous saline leads to rare bacteria outbreak

Improper handling of intravenous saline at a West Virginia outpatient oncology clinic was linked with the first reported outbreak of Tsukamurella spp., gram-positive bacteria that rarely cause disease in humans, in a new report from the Centers for Disease Control and Prevention (CDC). The report was published in the March issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

14 Feb 2014

TPI announces financial results for second quarter fiscal year 2014

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter fiscal year 2014.

14 Feb 2014

Highlights: Vaccine exemption bills rarely become law; Ariz. group urges public hospital changes; Florida foster kids care

Legislation to change whether parents may refuse school vaccinations for their children appears to be common in some states, according to a new analysis. However, those bills are rarely passed into law. Researchers identified 36 bills that were introduced in 18 state legislatures between 2009 and 2012 to change school immunization requirements. Most of those bills aimed to allow more parents the ability to refuse vaccinations for their children (Seaman, 2/12).

14 Feb 2014

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Three blog posts and a column should probably suffice to cover the debate over Obamacare and work incentives, but I don't want to let the topic drop without first stepping back and talking about the actual health policy disagreement here.

14 Feb 2014

HHS enrollment figures indicate sign-ups even in states where officials have opposed the health law

News outlets offer a sampling of state-specific health plan enrollment numbers. Even Oregon, with its non-working exchange, signed up more than 33,000 people.

14 Feb 2014

FDA approves Biologics’ IMBRUVICA as oral agent for treatment of patients with CLL

Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

14 Feb 2014

Healthcare News and Research

Latest Healthcare News and Research

The obese, people with AIDS encounter coverage gaps

Researchers use new technique that can partially move tumors from inoperable locations in brain

Highlights: N.D. hospital and abortion docs; Calif. sugary beverage bill; aging home care workers in Texas

Study explains clinical, public health challenges for use of statins in treatment of heart attacks

Viewpoints: Parsing Obamacare numbers; experts on long-term care insurance; French cancer care

Some having new luck with healthcare.gov, but others remain stuck

Leicester research reveals how noise damages hearing system

Some states beating others to health law enrollment punch

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Finding the meaning behind new Obamacare enrollment numbers

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

Research roundup: Examining readmissions; easing doctor burnout

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

First Edition: February 14, 2014

Improper handling of intravenous saline leads to rare bacteria outbreak

TPI announces financial results for second quarter fiscal year 2014

Highlights: Vaccine exemption bills rarely become law; Ariz. group urges public hospital changes; Florida foster kids care

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

HHS enrollment figures indicate sign-ups even in states where officials have opposed the health law

FDA approves Biologics’ IMBRUVICA as oral agent for treatment of patients with CLL

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in